Drug Pipeline

Lanreotide Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
3
Recruiting
2
Phase 3
4
Top Sponsors
Active Studies by Phase
Phase 3
2
Phase 2
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05477576 Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET… GEP-NET Recruiting
NCT06807437 Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a… Pancreatic Carcinoma Recruiting
Phase 2
NCT03946527 LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA) Paraganglioma Active, Not Recruiting
Phase 1/2
NCT05048901 Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine Tumors Neuroendocrine Tumors,Gastroenteropancreatic Recruiting
Sponsors Running Lanreotide Trials
Antonio Fojo (1) National Health Research Institutes, Taiwan (1) RayzeBio, Inc. (1) SWOG Cancer Research Network (1)
Disease Areas
Glioma (1) Pancreatic Cancer (1)
Get alerts when Lanreotide trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free